Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,021 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

NCT07155226

Conditions
Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Bone Marrow Diseases, +15 more
Locations
  • Research Site Decatur, Illinois, United States
  • Research Site New York, United States
  • Research Site Chapel Hill, North Carolina, United States
  • Research Site Durham, North Carolina, United States
View all 30 locations
View Trial Details
Recruiting

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

NCT03011814

Conditions
Folliculotropic Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT07218341

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Mitchell Cancer Institute Mobile, Alabama, United States
  • Arizona Oncology Associates, P.C. - HOPE Tucson, Arizona, United States
  • Cancer Specialists, LLC Jacksonville, Florida, United States
  • Minnesota Oncology Hematology, P.A. Coon Rapids, Minnesota, United States
View all 50 locations
View Trial Details
Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

NCT06549595

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Huntsville, Alabama, United States
  • Research Site Anchorage, Alaska, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Clovis, California, United States
View all 224 locations
View Trial Details

Related conditions